Systemic therapy in breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor Axilla MCF-7 Cells Tumor Cells, Cultured Neoplastic Cells, Circulating Lymph Nodes Mammary Glands, Human Nipples Neoplastic Stem Cells Epithelial Cells

Organisms2

Mice, Nude Mice, SCID

Diseases53

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Breast Diseases Neoplasm Invasiveness Neoplasm Recurrence, Local Lymphatic Metastasis Breast Neoplasms, Male Carcinoma, Lobular Carcinoma Disease Progression Lung Neoplasms Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Ovarian Neoplasms Bone Neoplasms Prostatic Neoplasms Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Neoplasms Liver Neoplasms Fibrocystic Breast Disease Neoplastic Cells, Circulating Adenocarcinoma Pancreatic Neoplasms Kidney Neoplasms Colorectal Neoplasms Carcinoma, Ductal Colonic Neoplasms Carcinoma in Situ Melanoma Stomach Neoplasms Cell Transformation, Neoplastic Psoriasis Neoplasms, Second Primary Triple Negative Breast Neoplasms Neovascularization, Pathologic Carcinoma, Renal Cell Inflammatory Breast Neoplasms Skin Neoplasms Carcinoma, Non-Small-Cell Lung Fibroadenoma Carcinoma, Squamous Cell Urinary Bladder Neoplasms Uterine Cervical Neoplasms Carcinoma, Hepatocellular Neoplasms, Basal Cell Recurrence Brain Neoplasms Panuveitis Head and Neck Neoplasms Neoplasms, Radiation-Induced Gastrointestinal Neoplasms

Chemicals and Drugs60

Receptors, Estrogen Tamoxifen Receptor, erbB-2 Antineoplastic Agents Receptors, Progesterone Antineoplastic Agents, Hormonal Tumor Markers, Biological Neoplasm Proteins Aromatase Inhibitors Antibodies, Monoclonal, Humanized Fluorouracil Estrogen Receptor alpha Estrogens Cyclophosphamide BRCA2 Protein Antibodies, Monoclonal BRCA1 Protein DNA, Neoplasm RNA, Messenger Estrogen Antagonists Anthracyclines Methotrexate Dermatologic Agents Ki-67 Antigen Paclitaxel Estradiol RNA, Small Interfering Doxorubicin Receptor, Epidermal Growth Factor Estrogen Receptor Modulators Deoxycytidine Epirubicin Selective Estrogen Receptor Modulators Nitriles Tumor Suppressor Protein p53 Taxoids Tumor Suppressor Proteins Protein Kinase Inhibitors RNA, Neoplasm Cancer Vaccines Antigens, Neoplasm Cisplatin Quinazolines Anticarcinogenic Agents Antigens, CD24 Phenylurea Compounds Niacinamide Triazoles Mucin-1 Transcription Factors Antimetabolites, Antineoplastic Benzenesulfonates Indoles MicroRNAs Antibiotics, Antineoplastic DNA-Binding Proteins Radiopharmaceuticals Pyrroles Angiogenesis Inhibitors Fluocinolone Acetonide

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Chemotherapy, Adjuvant Prognosis Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Mastectomy Mammography Treatment Outcome Survival Analysis Disease-Free Survival Combined Modality Therapy Survival Rate Mastectomy, Segmental Risk Factors Follow-Up Studies Early Detection of Cancer Retrospective Studies Neoadjuvant Therapy Radiotherapy, Adjuvant Immunohistochemistry Gene Expression Profiling Prospective Studies Clinical Trials as Topic Case-Control Studies Risk Assessment Breast Self-Examination Mammary Neoplasms, Experimental Multivariate Analysis Risk Kaplan-Meier Estimate Cohort Studies Incidence Reverse Transcriptase Polymerase Chain Reaction Predictive Value of Tests Xenograft Model Antitumor Assays Molecular Targeted Therapy Odds Ratio Tumor Burden Sensitivity and Specificity Neoplasm Transplantation Sentinel Lymph Node Biopsy Proportional Hazards Models Radiotherapy Lymph Node Excision Blotting, Western Registries Ultrasonography, Mammary Drug Administration Schedule Transplantation, Heterologous Oligonucleotide Array Sequence Analysis SEER Program Tissue Array Analysis Questionnaires Metastasectomy Logistic Models Randomized Controlled Trials as Topic Breast Implants Antineoplastic Protocols Reproducibility of Results Mass Screening Neoplasm Grading Transfection Polymerase Chain Reaction Mammaplasty Confidence Intervals Immunoenzyme Techniques Drug Delivery Systems Genetic Testing Drug Screening Assays, Antitumor Palliative Care Biopsy, Needle Estrogen Replacement Therapy Radiotherapy Dosage Patient Selection Gene Knockdown Techniques Immunotherapy Positron-Emission Tomography Biopsy Lymphatic Irradiation Preoperative Care In Situ Hybridization, Fluorescence

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA1 Postmenopause Genetic Predisposition to Disease Breast Feeding Cell Proliferation Premenopause Risk Menopause Time Factors Genes, BRCA2 Genes, erbB-2 Odds Ratio Mutation Sensitivity and Specificity Apoptosis Signal Transduction Cell Movement Cell Division Genotype Germ-Line Mutation Dose-Response Relationship, Drug Down-Regulation Polymorphism, Genetic DNA Methylation Promoter Regions, Genetic Cell Growth Processes Gene Amplification Transfection Cell Cycle RNA Interference Parity Up-Regulation Gene Silencing Cell Survival Gene Expression Genes, Tumor Suppressor Phenotype Genes, Neoplasm Phosphorylation Base Sequence Epithelial-Mesenchymal Transition Genes, p53

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science6

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care36

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Risk Factors Follow-Up Studies Retrospective Studies Prospective Studies Clinical Trials as Topic Case-Control Studies Risk Assessment Multivariate Analysis Risk Age Factors Kaplan-Meier Estimate Cohort Studies Incidence Predictive Value of Tests Odds Ratio Sensitivity and Specificity Proportional Hazards Models Registries National Cancer Institute (U.S.)SEER Program Questionnaires Logistic Models Randomized Controlled Trials as Topic Antineoplastic Protocols Reproducibility of Results Mass Screening Confidence Intervals Parity Genetic Testing Palliative Care Patient Selection Preoperative Care

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen Tamoxifen Receptor, erbB-2 Chemotherapy, Adjuvant Neoplasm Metastasis Prognosis Cell Line, Tumor Antineoplastic Agents Receptors, Progesterone Neoplasm Staging Breast Diseases Gene Expression Regulation, Neoplastic Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Hormonal Tumor Markers, Biological Mastectomy Neoplasm Invasiveness Mammography Treatment Outcome Survival Analysis Disease-Free Survival Neoplasm Recurrence, Local Combined Modality Therapy Survival Rate Lymphatic Metastasis Mastectomy, Segmental Risk Factors Breast Neoplasms, Male Carcinoma, Lobular Follow-Up Studies Axilla Early Detection of Cancer Retrospective Studies Carcinoma Drug Resistance, Neoplasm Neoadjuvant Therapy Genes, BRCA1 Neoplasm Proteins Radiotherapy, Adjuvant Postmenopause Mice, Nude Disease Progression Lung Neoplasms Aromatase Inhibitors Antibodies, Monoclonal, Humanized Immunohistochemistry Gene Expression Profiling Carcinoma, Intraductal, Noninfiltrating MCF-7 Cells Prospective Studies Genetic Predisposition to Disease Clinical Trials as Topic Fluorouracil Breast Feeding Ovarian Neoplasms Bone Neoplasms Cell Proliferation Premenopause Tumor Cells, Cultured Estrogen Receptor alpha Case-Control Studies Estrogens Risk Assessment Breast Self-Examination Prostatic Neoplasms Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Multivariate Analysis Risk Neoplasms Cyclophosphamide Age Factors Kaplan-Meier Estimate Menopause BRCA2 Protein Time Factors Cohort Studies Antibodies, Monoclonal Incidence Genes, BRCA2 BRCA1 Protein Reverse Transcriptase Polymerase Chain Reaction Liver Neoplasms Fibrocystic Breast Disease DNA, Neoplasm RNA, Messenger Predictive Value of Tests Xenograft Model Antitumor Assays Estrogen Antagonists Survivors United States Molecular Targeted Therapy Neoplastic Cells, Circulating Genes, erbB-2 Odds Ratio Tumor Burden Mutation

No FAQ available that match "systemic therapy in breast cancer"